Clinical TrialsSearch results
Number of results: 68732
Completed
- A Phase 3, Randomized, Double-Blind, Active-Controlled, Confirmatory Study to Compare the Immunogenicity, Efficacy, and Safety of KD-414 Vaccine and Vaxzevria Vaccine in Adults Aged 18 to 40 Years Old (COVID-19)
- Prevention of COVID-19 infection
- Fushimi Hideki
- 2022-03-18
Completed
- A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Trial Evaluating HZN-001 (teprotumumab) Treatment in Japanese Patients with Active Thyroid Eye Disease
- Active thyroid eye disease
- Oyama Fujiyo
- 2021-11-26
Completed
- A Phase 3, Randomized, Multicenter, Open-label, Active-comparator Controlled Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Machaidze Zurab
- 2022-03-04
Completed
- A Phase 3, Randomized, Open-Label, Controlled, Multicenter Study of Zandelisib (ME-401) in Combination with Rituximab Versus Standard Immunochemotherapy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - The COASTAL Study
- Follicular Lymphoma, Marginal zone lymphoma
- Hanaya Miyoko
- 2023-05-15
Completed
- A phase I clinical study of KSP-0243
- Healthy Condition
- Shimizu Yoshitaka
- 2021-01-20
Completed
- A Phase I Dose Escalation and Food Effect Study of Isotretinoin
- Severe acne vulgaris
- Toida Tsuneyuki
- 2022-11-25
Completed
- A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD7442 in Healthy Japanese Participants
- COVID-19
- Hibi Kazushige
- 2021-03-10
Completed
- A Phase I Single Ascending Dose Study of RO7126209 in Healthy Japanese Subjects
- Alzheimer's disease
- Nanki Toshihiro
- 2021-05-17
Completed
- A PHASE I SINGLE CENTER, OPEN-LABEL, COMBINATION STUDY OF RM-1929 AND PHOTOIMMUNOTHERAPY IN PATIENTS WITH RECURRENT SQUAMOUS CELL HEAD AND NECK CANCER
- Squamous Cell Carcinoma of Head and Neck
- Arron Sarah
- 2020-09-30
Completed
- A PHASE I STUDY OF CASIRIVIMAB AND IMDEVIMAB IN JAPANESE ADULT VOLUNTEERS
- coronavirus disease 2019(COVID-19)
- Nanki Toshihiro
- 2021-03-29